A Population Pharmacokinetic Meta-analysis of Sunitinib Malate (SU11248) and Its Primary Metabolite (SU12662) in Healthy Volunteers and Oncology Patients

Brett E. Houk; Carlo L. Bello; Dongwoo Kang; Michael Amantea

doi:10.1158/1078-0432.CCR-08-1893

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

Cancer Therapy: Clinical

A Population Pharmacokinetic Meta-analysis of Sunitinib Malate (SU11248) and Its Primary Metabolite (SU12662) in Healthy Volunteers and Oncology Patients

Brett E. Houk, Carlo L. Bello, Dongwoo Kang and Michael Amantea

Brett E. Houk

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Carlo L. Bello

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dongwoo Kang

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael Amantea

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

DOI: 10.1158/1078-0432.CCR-08-1893 Published April 2009

Article
Figures & Data
Info & Metrics
PDF

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: March 2009 to April 2021

	Abstract	Full-text HTML	PDF
Total	4164	6317	5490

Cited By

Article Information

Volume 15, Issue 7, pp. 2497-2506

DOI

https://doi.org/10.1158/1078-0432.CCR-08-1893

PubMed

19258444

Published By

American Association for Cancer Research

Print ISSN

1078-0432

Online ISSN

1557-3265

History

Accepted December 24, 2008
Received July 21, 2008
Revision received November 27, 2008
Published first March 3, 2009.

American Association for Cancer Research

Author Information

Brett E. Houk,
Carlo L. Bello,
Dongwoo Kang and
Michael Amantea

Authors' Affiliation: Department of Clinical Pharmacology, Pfizer, Inc., La Jolla, California

Requests for reprints:
Brett E. Houk, Department of Clinical Pharmacology, Pfizer, Inc., 10578 Science Center Drive, CB10, San Diego, CA 92121. Phone: 858-622-7488; Fax: 858-882-8727; E-mail: Brett.Houk{at}pfizer.com.

View Full Text

PreviousNext

April 2009
Volume 15, Issue 7

Table of Contents
Table of Contents (PDF)
About the Cover

Search for this keyword

View this article with LENS

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following A Population Pharmacokinetic Meta-analysis of Sunitinib Malate (SU11248) and Its Primary Metabolite (SU12662) in Healthy Volunteers and Oncology Patients

Message Subject (Your Name) has forwarded a page to you from Clinical Cancer Research

Message Body (Your Name) thought you would be interested in this article in Clinical Cancer Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

A Population Pharmacokinetic Meta-analysis of Sunitinib Malate (SU11248) and Its Primary Metabolite (SU12662) in Healthy Volunteers and Oncology Patients

Brett E. Houk, Carlo L. Bello, Dongwoo Kang and Michael Amantea

Clin Cancer Res April 1 2009 (15) (7) 2497-2506; DOI: 10.1158/1078-0432.CCR-08-1893

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

A Population Pharmacokinetic Meta-analysis of Sunitinib Malate (SU11248) and Its Primary Metabolite (SU12662) in Healthy Volunteers and Oncology Patients

Brett E. Houk, Carlo L. Bello, Dongwoo Kang and Michael Amantea

Clin Cancer Res April 1 2009 (15) (7) 2497-2506; DOI: 10.1158/1078-0432.CCR-08-1893

Share This Article: